Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » ACM Research releases preliminary version for Q3 2024
Research

ACM Research releases preliminary version for Q3 2024

Paul E.By Paul E.October 17, 2024No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


FREMONT, Calif., Oct. 17, 2024 (Globe Newswire) — ACM Research, Inc. (“ACM”) (NASDAQ: ACMR) today announced its preliminary earnings range for the third quarter of 2024, ahead of the United States. It was announced that it would be announced. The market will open on Wednesday, October 30, 2024, in line with the reporting obligations of ACM Research (Shanghai), Inc., ACM’s principal operating subsidiary, to the Shanghai Stock Exchange.

ACM will release its full financial results for the third quarter of 2024 before U.S. markets open on Thursday, November 7, 2024. ACM will hold a conference call corresponding to 8:00 a.m. ET (9:00 p.m. China time). Discuss the results.

Content: ACM Third Quarter (Ending September 30, 2024) Earnings Announcement Date and Time: Thursday, November 7, 2024, 8:00 a.m. ET Webcast: ir.acmrcsh.com/events

To join the conference call by phone, participants must complete the online registration process using the link below. Once registered, each participant will receive instructions via email to access the conference call, including dial-in information and a PIN number that will authorize access to the conference call. This pre-registration process is designed by operators to reduce delays due to operator congestion when accessing live calls.

Register online: https://register.vevent.com/register/BI784dead480b140a3b5c60f71a7c32c6b

Attendees who have not pre-registered can join the webcast by following the link at ir.acmrcsh.com/events.

A live and archived webcast of the conference call will be available on the Investor section of ACM’s website at www.acmrcsh.com.

About ACM Research Inc.

ACM develops semiconductor processing equipment for single-wafer and batch wet cleaning, electroplating, stress-free polishing, vertical furnace processing, track and PECVD essential for advanced semiconductor device manufacturing and wafer-level packaging. , manufactures and sells. ACM is committed to providing customized, high-performance, cost-effective process solutions that semiconductor manufacturers can use across numerous manufacturing steps to increase productivity and product yield. For more information, please visit www.acmrcsh.com.

© ACM Research, Inc. The ACM Research logo is a trademark of ACM Research, Inc. For convenience, this press release lists this trademark without the ™ symbol, but this does not imply that ACM does not claim it to the fullest extent possible. its rights to such trademarks under applicable law;

For investor and media inquiries, please contact:



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleInsights and best practices to accelerate your healthcare career
Next Article Press Release: Pace University holds largest career fair in university history
Paul E.
  • Website

Related Posts

Chronic absences have not disappeared. Research shows that poor children are most hurt.

June 5, 2025

American Brain Tumor Society’s Metastatic Brain Tumor Collaborative Announces $50,000 Research Grant Opportunity to Fund High-Risk, High-Impact CNS Metastasis Research

October 31, 2024

Massive yard sale in Newtown benefits pancreatic cancer research

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.